In Conversation: Matthew McKnight, Chief Commercial Officer, Ginkgo Bioworks

In Conversation: Matthew McKnight, Chief Commercial Officer, Ginkgo Bioworks

Synthetic.com’s publisher and editor, Simons Chase, interviews Matthew McKnight. Matt is the Chief Commercial Officer of Ginkgo Bioworks where he also leads the company’s biosecurity platform, Concentric by Ginkgo. Prior to Ginkgo, Matt spent 7 years as an investor at IndUS Growth Partners and was the President and COO of Decision Resources Group. He has … Read more

Categories IPO

Chinese Firm’s Collection Of Global Prenatal DNA Could Fuel Ethno-Nationalist Aims

Chinese Firm’s Collection Of Global Prenatal DNA Could Fuel Ethno-Nationalist Aims

BGI Group, a Chinese gene company, is collecting genetic data through prenatal tests from women in more than 50 countries for research on the traits of populations, raising concern that such a large DNA database could give China a technological advantage and the strategic edge to dominate global pharmaceuticals, according to a recent news report. … Read more

Genome Medical Raises C Round Led By Casdin, Acquires Telehealth Genetic Counseling Company

Genome Medical Raises C Round Led By Casdin, Acquires Telehealth Genetic Counseling Company

Genome Medical, a genomic care delivery company, today announced that it will acquire GeneMatters, a telehealth genetic counseling and software solutions company.  The company also announced the closing of a $60 million Series C financing to accelerate commercial traction and advance its mission to advance genomic medicine.   “The addition of GeneMatters, along with our … Read more

IPO: Verve Therapeutics Takes On Cardiovascular Disease Using Gene Editing

IPO: Verve Therapeutics Takes On Cardiovascular Disease Using Gene Editing

Verve Therapeutics, a biotech company innovating new approaches to the care of cardiovascular disease with single-course gene editing medicines, announced terms for its $201 million IPO on today. Insiders Wellington Management and Casdin Capital and new investor Fidelity have indicated an interest in purchasing up to an aggregate $75 million worth of shares in the … Read more

Entrepreneurs Accelerate The Search for Early Detection of Pancreatic Cancer

Entrepreneurs Accelerate The Search for Early Detection of Pancreatic Cancer

Scientists have identified more than 1,000 potential new biomarkers for cancer that they hope will aid in the early detection of many of these complex diseases, including one of the most challenging, pancreatic cancer. In the alternate universe of reward-sensitive entrepreneurs, Jo Bhakdi has rolled out a new liquid biopsy product that detects potentially cancerous … Read more

World’s Biggest Growth Investors Pool Assets To SPAC & PIPE Ginko Bioworks

World’s Biggest Growth Investors Pool Assets To SPAC & PIPE Ginko Bioworks

Ginkgo Bioworks, Inc.’s (“Ginkgo”) founders have been working together for nearly twenty years since they first met at MIT. They launched Ginkgo in 2008 with the consistent goal of developing a platform that makes cell programming easier for their customers and partners. Ginkgo’s platform leverages advanced robotic automation, proprietary software, and data analytics to continuously … Read more

Categories IPO

Biosensing Takes A Leap With Synex Medical

Biosensing Takes A Leap With Synex Medical

Biosensing is the main component of the future personal area network. The Apple Watch is the most widely known biosensing device. The latest version (Series 6, released September 2020) sparkles with features that lean perpetually towards health including a class II FDA clearance for electrocardiogram for atrial fibrillation (AFib) detection and wellness-grade daily blood oxygen … Read more